Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes

The aim of this study was to test suitable culture conditions for maintaining normal cellular cytoarchitecture and inducibility of P450 enzymes in primary cultures of human hepatocytes by prototypical inducers. The selectivity and sensitivity of a sandwich culture system were determined by treating cultures with a number of clinically relevant drugs that are known to be inducers of either rodent and/or human P450 enzymes. The results showed that considerable induction of CYP3A4 activity is observed at DMSO concentrations greater than 0.1% (v/v). No differences in P450 induction response were observed between cultures maintained under different matrix conditions. However, the matrix condition considered to be optimal for maintaining cellular integrity, protein yields, and P450 enzyme induction was a sandwich configuration in combination with modified Chee’s medium containing insulin (6.25 μg/mL) and dexamethasone (≤0.1 μM). Under these conditions, induction of CYP3A4 occurred at clinically relevant drug concentrations, and maximal activities were achieved after 3 days of exposure. Overall, the response of human hepatocyte cultures to treatment with both positive and negative modulators was found to reflect that observed in vivo with respect to both enzyme specificity and potency of enzyme induction, although considerable sample‐to‐sample variability was observed in the magnitude of induction. © 2000 John Wiley & Sons, Inc. J Biochem Toxicol 14:177–188, 2000

[1]  Charles W. Dunnett,et al.  New tables for multiple comparisons with a control. , 1964 .

[2]  A. Conney Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[3]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[4]  P. Thomas,et al.  The in vivo turnover of rat liver microsomal epoxide hydrolase and both the apoprotein and heme moieties of specific cytochrome P-450 isozymes. , 1983, Archives of biochemistry and biophysics.

[5]  S. Safe,et al.  Differential time course of induction of rat liver microsomal cytochrome P-450 isozymes and epoxide hydrolase by Aroclor 1254. , 1983, Archives of biochemistry and biophysics.

[6]  J. Knoben,et al.  "Handbook of clinical drug data". , 1983, Canadian Medical Association journal.

[7]  P. Watkins,et al.  Identification of an inducible form of cytochrome P-450 in human liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Watkins,et al.  Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. , 1985, Biochemistry.

[9]  P. Watkins,et al.  Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[11]  P. Beaune,et al.  The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. , 1989, British journal of clinical pharmacology.

[12]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[13]  P. Beaune,et al.  Expression of cytochrome P-450 enzymes in cultured human hepatocytes. , 1990, European journal of biochemistry.

[14]  D. Waxman,et al.  Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. , 1990, The Biochemical journal.

[15]  P. Maurel,et al.  Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[16]  E. Schuetz,et al.  Hepatocyte culture in study of P450 regulation. , 1991, Methods in enzymology.

[17]  M. Sharratt,et al.  Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. , 1991, Annual review of pharmacology and toxicology.

[18]  A. Parkinson,et al.  Production and purification of antibodies against rat liver P450 enzymes. , 1991, Methods in enzymology.

[19]  Albert P. Li,et al.  Isolation and culturing of hepatocytes from human livers , 1992 .

[20]  J. Buters,et al.  A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. , 1993, Biochemical pharmacology.

[21]  J. S. Sidhu,et al.  Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. , 1993, Archives of biochemistry and biophysics.

[22]  J. Domergue,et al.  Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. , 1994, The Journal of pharmacology and experimental therapeutics.

[23]  I. Roots,et al.  Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test , 1994, Clinical pharmacology and therapeutics.

[24]  I. Roots,et al.  Specific and dose‐dependent enzyme induction by omeprazole in human beings , 1994, Hepatology.

[25]  R. Fisher,et al.  Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[26]  J. Hochman,et al.  Cultured rat hepatocytes. , 1996, Pharmaceutical biotechnology.

[27]  Andrew Parkinson,et al.  Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes , 1996 .

[28]  P. Maurel The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man , 1996 .

[29]  A. Parkinson An Overview of Current Cytochrome P450 Technology for Assessing the Safety and Efficacy of New Materials , 1996, Toxicologic pathology.

[30]  A. Parkinson,et al.  Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. , 1996, Archives of biochemistry and biophysics.

[31]  S. Strom,et al.  Use of human hepatocytes to study P450 gene induction. , 1996, Methods in enzymology.

[32]  C. Bonfils,et al.  Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture , 1997, Hepatology.

[33]  S. Ekins,et al.  Examination of purported probes of human CYP2B6. , 1997, Pharmacogenetics.

[34]  R Ohlsson,et al.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Kennedy,et al.  Refinement of an in vitro cell model for cytochrome P450 induction. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[36]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[37]  K. Carroll,et al.  Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[38]  S. Wrighton,et al.  The use of human hepatocyte cultures to study the induction of cytochrome P-450. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[39]  A. Li,et al.  Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. , 1999, Chemico-biological interactions.

[40]  L. Moore,et al.  The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution , 2000 .